Using continuous glucose monitors to help manage obesity in kids and teens
Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
NA · University of California, Los Angeles · NCT06254768
This study tests if using continuous glucose monitors can help kids and teens with obesity manage their weight by seeing how it affects their eating habits and activity levels.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 10 Years to 21 Years |
| Sex | All |
| Sponsor | University of California, Los Angeles (other) |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT06254768 on ClinicalTrials.gov |
What this trial studies
This study investigates the feasibility of using continuous glucose monitors (CGMs) in children and adolescents with obesity to aid in weight management. It is a cross-over trial where participants will experience both blinded and unblinded CGM use over a six-week period. The study aims to determine how access to glucose trends can influence eating behaviors and physical activity levels, without any additional lifestyle modification recommendations. The primary focus is on recruitment, retention, and adherence, while secondary outcomes include changes in weight, dietary intake, and physical activity.
Who should consider this trial
Good fit: Ideal candidates are children and adolescents aged 10-21 years with a BMI greater than the 95th percentile.
Not a fit: Patients with a previous diagnosis of Prader Willi Syndrome, intellectual disabilities, or those who have undergone bariatric surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a new tool for managing obesity in youth by promoting healthier eating habits and increased physical activity.
How similar studies have performed: While CGMs have been used in diabetes management, this specific application for obesity in youth is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 10-21 years BMI \>95th percentile Exclusion Criteria: * Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity * Intellectual disability * Previous or planned bariatric surgery * Hemoglobin A1c \>6.5 % * Current use of medication that impacts weight
Where this trial is running
Los Angeles, California
- Pediatric Endocrinology Division, University of California — Los Angeles, California, United States (RECRUITING)
Study contacts
- Study coordinator: Sri Nikhita Chimatapu, MD
- Email: schimatapu@mednet.ucla.edu
- Phone: 9177414080
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pediatric Obesity